Formula Used:
From: | To: |
The Volume of Plasma Cleared is defined as the amount of plasma cleared of the drug per unit of time. It is a key pharmacokinetic parameter that helps determine the elimination characteristics of a drug from the body.
The calculator uses the formula:
Where:
Explanation: This formula calculates the volume of plasma from which a drug is completely removed per unit time, based on the administered dose and the area under the plasma concentration-time curve.
Details: Calculating the volume of plasma cleared is crucial for understanding drug elimination rates, determining appropriate dosing regimens, and assessing the pharmacokinetic properties of medications in clinical practice and research.
Tips: Enter the dose in moles and the area under curve value in mole second per cubic meter. Both values must be positive numbers greater than zero for accurate calculation.
Q1: What does Volume of Plasma Cleared represent?
A: It represents the theoretical volume of plasma from which a drug is completely removed per unit time, indicating the efficiency of drug elimination from the body.
Q2: How is Area Under Curve (AUC) determined?
A: AUC is typically determined through blood sampling at various time points after drug administration and calculating the area under the plasma concentration-time curve using numerical integration methods.
Q3: What are typical units for Volume of Plasma Cleared?
A: The standard SI unit is cubic meters per second, though in clinical practice, liters per hour or milliliters per minute are more commonly used for practical measurement scales.
Q4: How does Volume of Plasma Cleared relate to drug half-life?
A: Volume of plasma cleared, along with volume of distribution, determines the elimination half-life of a drug through the relationship: half-life = (0.693 × volume of distribution) / clearance.
Q5: Can this calculation be used for all routes of administration?
A: This calculation is primarily used for intravenous administration where the entire dose reaches systemic circulation. For other routes, bioavailability factors must be considered.